4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000045
CEO bought 89,500 shares at an average $0.01 ($918)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-08 | Purchase : show line 1 in the form | +2,000 | $0.01 | $20 | 24,922,797 | D |
| 2019-08-08 | Purchase : show line 2 in the form | +3,000 | $0.01 | $30 | 24,925,797 | D |
| 2019-08-08 | Purchase : show line 3 in the form | +5,000 | $0.01 | $51 | 24,930,797 | D |
| 2019-08-08 | Purchase : show line 4 in the form | +5,000 | $0.01 | $51 | 24,935,797 | D |
| 2019-08-08 | Purchase : show line 5 in the form | +10,000 | $0.01 | $100 | 24,945,797 | D |
| 2019-08-08 | Purchase : show line 6 in the form | +50 | $0.01 | $1 | 24,945,847 | D |
| 2019-08-08 | Purchase : show line 7 in the form | +19,950 | $0.01 | $201 | 24,965,797 | D |
| 2019-08-08 | Purchase : show line 8 in the form | +10,000 | $0.01 | $101 | 24,975,797 | D |
| Open-market purchases · 89,500 sh · avg $0.01 · $918 | ||||||
Loading xslF345X03/primary_doc.xml…